GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (OTCPK:BVNRY) » Definitions » Effective Interest Rate on Debt %

BVNRY (Bavarian Nordic AS) Effective Interest Rate on Debt % : 36.05% (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bavarian Nordic AS Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Bavarian Nordic AS's annualized positive value of Interest Expense for the quarter that ended in Dec. 2024 was $6.3 Mil. Bavarian Nordic AS's average total debt for the quarter that ended in Dec. 2024 was $17.5 Mil. Therefore, Bavarian Nordic AS's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 was 36.05%.


Bavarian Nordic AS Effective Interest Rate on Debt % Historical Data

The historical data trend for Bavarian Nordic AS's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Effective Interest Rate on Debt % Chart

Bavarian Nordic AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.57 18.56 8.07 11.36 55.69

Bavarian Nordic AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.73 62.30 65.91 79.92 36.05

Competitive Comparison of Bavarian Nordic AS's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Bavarian Nordic AS's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic AS's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Effective Interest Rate on Debt % falls into.


;
;

Bavarian Nordic AS Effective Interest Rate on Debt % Calculation

Bavarian Nordic AS's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2023 )+Total Debt  (A: Dec. 2024 ))/ count )
=-1  *  -10.934/( (21.259+18.007)/ 2 )
=-1  *  -10.934/19.633
=55.69 %

where

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=14.449 + 6.81
=21.259

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=12.174 + 5.833
=18.007

Bavarian Nordic AS's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Sep. 2024 )+Total Debt  (Q: Dec. 2024 ))/ count )
=-1  *  -6.312/( (17.014+18.007)/ 2 )
=-1  *  -6.312/17.5105
=36.05 %

where

Total Debt  (Q: Sep. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=11.409 + 5.605
=17.014

Total Debt  (Q: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=12.174 + 5.833
=18.007

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Bavarian Nordic AS  (OTCPK:BVNRY) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Bavarian Nordic AS Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic AS Business Description

Industry
Address
Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines